Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Flx475
2. Flx-475
3. 2174938-78-2
4. Unii-r1t69t65fj
5. R1t69t65fj
6. Schembl19816090
7. Gtpl12153
8. Ex-a6867
9. Example 43 [wo2018022992a1]
10. 1-piperidineethanol, 3-(1-(1-((1r)-1-(2,4-dichlorophenyl)ethyl)-3-(trifluoromethyl)-1h-pyrazolo(3,4-b)pyrazin-6-yl)-3-azetidinyl)-, (3r)-
| Molecular Weight | 543.4 g/mol |
|---|---|
| Molecular Formula | C24H27Cl2F3N6O |
| XLogP3 | 4.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | 542.1575494 g/mol |
| Monoisotopic Mass | 542.1575494 g/mol |
| Topological Polar Surface Area | 70.3 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 747 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
15
PharmaCompass offers a list of FLX475 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right FLX475 manufacturer or FLX475 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred FLX475 manufacturer or FLX475 supplier.
PharmaCompass also assists you with knowing the FLX475 API Price utilized in the formulation of products. FLX475 API Price is not always fixed or binding as the FLX475 Price is obtained through a variety of data sources. The FLX475 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tivumecirnon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tivumecirnon, including repackagers and relabelers. The FDA regulates Tivumecirnon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tivumecirnon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tivumecirnon supplier is an individual or a company that provides Tivumecirnon active pharmaceutical ingredient (API) or Tivumecirnon finished formulations upon request. The Tivumecirnon suppliers may include Tivumecirnon API manufacturers, exporters, distributors and traders.
Tivumecirnon Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tivumecirnon GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tivumecirnon GMP manufacturer or Tivumecirnon GMP API supplier for your needs.
A Tivumecirnon CoA (Certificate of Analysis) is a formal document that attests to Tivumecirnon's compliance with Tivumecirnon specifications and serves as a tool for batch-level quality control.
Tivumecirnon CoA mostly includes findings from lab analyses of a specific batch. For each Tivumecirnon CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tivumecirnon may be tested according to a variety of international standards, such as European Pharmacopoeia (Tivumecirnon EP), Tivumecirnon JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tivumecirnon USP).
